SARS-CoV-2 in multiple myeloma: initial observation and management

Leuk Lymphoma. 2020 Nov;61(11):2763-2766. doi: 10.1080/10428194.2020.1780588. Epub 2020 Jun 17.

Authors

Affiliations

¹ Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
² Department of Internal Medicine/Infectious Disease, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
³ Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁴ Radiodiagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Betacoronavirus
COVID-19
Coronavirus Infections / complications*
Coronavirus Infections / transmission
Coronavirus Infections / virology
Disease Management
Female
Humans
Male
Middle Aged
Multiple Myeloma / complications
Multiple Myeloma / diagnosis
Multiple Myeloma / therapy*
Multiple Myeloma / virology*
Pandemics
Pneumonia, Viral / complications*
Pneumonia, Viral / transmission
Pneumonia, Viral / virology
Prognosis
SARS-CoV-2

Grants and funding